XML 87 R64.htm IDEA: XBRL DOCUMENT v3.25.0.1
Financial Instruments and Risk Management (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Notional Amounts of Outstanding Derivative Instruments
As of December 31, 2024, the Company had the following outstanding derivative instruments that were entered into to hedge Euro-denominated and Singapore dollar-denominated forecasted transactions:
In millions of EurosNotional amount for hedge on
forecasted R&D and other
operating expenses
Notional amount for hedge on
forecasted manufacturing costs
Forward contracts5811,063
Currency collars247380
 
In millions of Singapore dollarsNotional amount for hedge on
forecasted R&D and other
operating expenses
Notional amount for hedge on
forecasted manufacturing costs
Forward contracts168
Fair Value of Derivative Instruments
Information on fair value of derivative instruments and their location in the consolidated balance sheets as of December 31, 2024 and December 31, 2023 is presented in the table below:

As of December 31,
2024
As of December 31,
2023
Asset DerivativesBalance sheet classificationFair
value
Fair
value
Derivatives designated as a hedge:
Foreign exchange forward contractsOther current assets46
Foreign exchange forward contractsOther non-current assets2
Currency collarsOther current assets7
Total derivatives designated as a hedge:55
Derivatives not designated as a hedge:
Foreign exchange forward contractsOther current assets105
Total derivatives not designated as a hedge:105
Total Derivatives1060
As of December 31,
2024
As of December 31,
2023
Liability DerivativesBalance sheet classificationFair
value
Fair
value
Derivatives designated as a hedge:
Foreign exchange forward contractsOther payables and
accrued liabilities
(66)(2)
Foreign exchange forward contractsOther non-current liabilities(3)
Currency collarsOther payables and
accrued liabilities
(15)
Total derivatives designated as a hedge:(84)(2)
Derivatives not designated as a hedge:
Foreign exchange forward contractsOther payables and
accrued liabilities
(5)(2)
Total derivatives not designated as a hedge:(5)(2)
Total Derivatives(89)(4)
Effect on Consolidated Statements of Income of Derivative Instruments
The effect of derivative instruments designated as cash flow hedge on the consolidated statements of income for the year ended December 31, 2024 and December 31, 2023 and on the “Accumulated other comprehensive income (loss)” (“AOCI”) as reported in the consolidated statements of equity as of December 31, 2024 and December 31, 2023 is presented in the table below:

Gain (loss) deferred in
OCI on derivative
Location of gain (loss)Gain (loss) reclassified from
OCI into earnings
December 31,
2024
December 31,
2023
reclassified from OCI into
earnings
December 31,
2024
December 31,
2023
Foreign exchange forward contracts(54)35 Cost of sales13 
Foreign exchange forward contracts(7)Selling, general and administrative expenses
Foreign exchange forward contracts(17)10 Research and development expenses
Currency collars(15)Cost of sales— — 
Currency collars(2)Selling, general and administrative expenses— — 
Currency collars(4)Research and development expenses— 
Total(99)57 16 5 
Effect on Consolidated Statements of Income of Derivative Instruments Not Designated as Hedge
The effect on the consolidated statements of income for the year ended December 31, 2024 and December 31, 2023 of derivative instruments not designated as a hedge is presented in the table below:
Location of gainGain (loss) recognized in earnings
(loss) recognized
in earnings
December 31,
2024
December 31,
2023
Foreign exchange forward contractsOther income and expenses, net92
Total92
Schedule of Financial Assets (Liabilities) Measured at Fair Value on Recurring Basis
The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2024:

Fair Value Measurements using
December 31,
2024
Quoted
Prices in
Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Marketable securities – U.S. Treasury debt securities2,452 2,452 — — 
Equity securities measured at fair value through earnings88 88 — — 
Derivative assets designated as cash flow hedge— — — — 
Derivative assets not designated as cash flow hedge10 — 10 — 
Derivative liabilities designated as cash flow hedge(84)— (84)— 
Derivative liabilities not designated as cash flow hedge(5)— (5)— 
Contingent consideration on business acquisition(15)— — (15)
Total2,446 2,540 (79)(15)
The table below details financial assets (liabilities) measured at fair value on a recurring basis as of December 31, 2023:
Fair Value Measurements using
December 31,
2023
Quoted
Prices in
Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Marketable securities – U.S. Treasury debt securities1,635 1,635 — — 
Equity securities measured at fair value through earnings31 31 — — 
Derivative assets designated as cash flow hedge55 — 55 — 
Derivative assets not designated as cash flow hedge— — 
Derivative liabilities designated as cash flow hedge(2)— (2)— 
Derivative liabilities not designated as cash flow hedge(2)— (2)— 
Contingent consideration on business acquisitions(20)— — (20)
Total1,702 1,666 56 (20)
Schedule of Liabilities Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs (Level 3)
For liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2023 and December 31, 2023 is presented as follows:
Fair Value
Measurements
using Significant
Unobservable
Inputs (Level 3)
January 1, 202331 
Changes in fair value measurement(12)
Currency translation adjustment
December 31, 202320 
Amount of total gains (losses) for the period included in earnings attributable to liabilities
   still held at the reporting date
12 
Fair Value Information on Other Financial Assets and Liabilities Recorded at Amortized Cost
The following table includes additional fair value information on financial assets and liabilities as of December 31, 2024 and 2023:
20242023
LevelCarrying
Amount
Estimated
Fair Value
Carrying
Amount
Estimated
Fair Value
Cash equivalents (1)
11,611 1,611 2,879 2,879 
Short-term, deposits11,450 1,450 1,226 1,226 
Long-term debt
– Bank loans (including current portion)21,389 1,389 1,366 1,366 
– Finance leases (including current portion)266 66 65 65 
– Senior unsecured convertible bonds issued on August 4, 2020 (2)
11,498 1,442 1,496 1,814 
(1)     Cash equivalents primarily correspond to deposits at call with banks and money market funds.
(2)     The carrying amount as of December 31, 2024, of the senior unsecured convertible bonds as reported above, corresponds to the nominal value of the bonds, net of $2 million unamortized debt issuance costs. The fair value represented the market price of the bonds trading on the Frankfurt Stock Exchange.
Schedule of Methodologies Used to Estimate Fair Value
The methodologies used to estimate fair value are as follows:
ComponentsMethodology used to estimate fair value
Debt securities classified as available-for-saleQuoted market prices for identical instruments
Foreign exchange forward contracts, currency options and collarsQuoted market prices for similar instruments
Equity securities measured at fair value through earningsQuoted market prices for identical instruments
Equity securities carried at cost as a measurement alternativeValuation of the underlying investments on a new round of third-party financing or upon liquidation
Long-term debt and current portion of long-term debt
Future cash flows on a borrowing-by-borrowing basis and discounting these future cash flows using the Company's incremental borrowing rates for similar types of borrowing arrangements. For convertible bonds, the fair value represents the market price of the bonds trading on the Frankfurt Stock Exchange
Cash and cash equivalents, short-term deposits, accounts receivable, short-term borrowings, and accounts payableThe carrying amounts reflected in the consolidated financial statements are considered as reasonable estimates of fair value due to the relatively short period of time between the origination of the instruments and their expected realization.